APO Research
Talk to an analyst

APO RESEARCH · REPORT

Adapalene Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Adapalene Drugs Industry Growth and Trends Forecast to 2032

28 December 2025106 pages

Choose your research edition.

Industry ResearchAdapalene Drugs Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Adapalene Drugs Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Adapalene Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Adapalene Drugs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Adapalene Drugs Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Adapalene Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Adapalene Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Adapalene Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Adapalene Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Adapalene Drugs include Wuhan Nuoan Pharmaceutical, Sichuan Med-Shine Pharmaceutical, Jiangsu Fubang Pharmaceutical, Heilongjiang Fuhe Pharmaceutical, HEC Pharm, Beijing Foyou Pharmaceutical, Taro Pharmaceutical, Sandoz and Glenmark, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Adapalene Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Adapalene Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Adapalene Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Adapalene Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Adapalene Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Adapalene Drugs Market by Company

Wuhan Nuoan Pharmaceutical

Sichuan Med-Shine Pharmaceutical

Jiangsu Fubang Pharmaceutical

Heilongjiang Fuhe Pharmaceutical

HEC Pharm

Beijing Foyou Pharmaceutical

Taro Pharmaceutical

Sandoz

Glenmark

Galderma

Encube Ethicals

Bausch Health

Alembic

Actavis

Adapalene Drugs Segment by Type

Gel

Solution

Cream

Others

Adapalene Drugs Segment by Application

Acne

Keratosis Pilaris

Others

Adapalene Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adapalene Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Adapalene Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adapalene Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Adapalene Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Adapalene Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Gel Table 2. Major Company of Solution Table 3. Major Company of Cream Table 4. Major Company of Others Table 5. Global Adapalene Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Adapalene Drugs Sales by Type (2021-2026) & (K Units) Table 7. Global Adapalene Drugs Sales Market Share in Volume by Type (2021-2026) Table 8. Global Adapalene Drugs Sales by Type (2021-2026) & (US$ Million) Table 9. Global Adapalene Drugs Sales Market Share in Value by Type (2021-2026) Table 10. Global Adapalene Drugs Price by Type (2021-2026) & (US$/Unit) Table 11. Global Adapalene Drugs Sales by Type (2027-2032) & (K Units) Table 12. Global Adapalene Drugs Sales Market Share in Volume by Type (2027-2032) Table 13. Global Adapalene Drugs Sales by Type (2027-2032) & (US$ Million) Table 14. Global Adapalene Drugs Sales Market Share in Value by Type (2027-2032) Table 15. Global Adapalene Drugs Price by Type (2027-2032) & (US$/Unit) Table 16. North America Adapalene Drugs Sales by Type (2021-2026) & (K Units) Table 17. North America Adapalene Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Adapalene Drugs Sales by Type (2021-2026) & (K Units) Table 19. Europe Adapalene Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Adapalene Drugs Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Adapalene Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Adapalene Drugs Sales by Type (2021-2026) & (K Units) Table 23. Latin America Adapalene Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Adapalene Drugs Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Adapalene Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Adapalene Drugs Industry Trends Table 27. Adapalene Drugs Industry Drivers Table 28. Adapalene Drugs Industry Opportunities and Challenges Table 29. Adapalene Drugs Industry Restraints Table 30. Global Adapalene Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Adapalene Drugs Revenue Market Share by Company (2021-2026) Table 32. Global Adapalene Drugs Sales by Company (2021-2026) & (K Units) Table 33. Global Adapalene Drugs Sales Share by Company (2021-2026) Table 34. Global Adapalene Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Adapalene Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Adapalene Drugs Major Company Production Sites and Headquarters Table 37. Global Adapalene Drugs Company, Product Type & Application Table 38. Global Adapalene Drugs Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Adapalene Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Adapalene Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Adapalene Drugs Sales by Region (2021-2026) & (K Units) Table 43. Global Adapalene Drugs Sales Market Share in Volume by Region (2021-2026) Table 44. Global Adapalene Drugs Sales by Region (2021-2026) & (US$ Million) Table 45. Global Adapalene Drugs Sales Market Share in Value by Region (2021-2026) Table 46. Global Adapalene Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Adapalene Drugs Sales by Region (2027-2032) & (K Units) Table 48. Global Adapalene Drugs Sales Market Share in Volume by Region (2027-2032) Table 49. Global Adapalene Drugs Sales by Region (2027-2032) & (US$ Million) Table 50. Global Adapalene Drugs Sales Market Share in Value by Region (2027-2032) Table 51. Global Adapalene Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Adapalene Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Adapalene Drugs Sales by Application (2021-2026) & (K Units) Table 54. Global Adapalene Drugs Sales Market Share in Volume by Application (2021-2026) Table 55. Global Adapalene Drugs Sales by Application (2021-2026) & (US$ Million) Table 56. Global Adapalene Drugs Sales Market Share in Value by Application (2021-2026) Table 57. Global Adapalene Drugs Price by Application (2021-2026) & (US$/Unit) Table 58. Global Adapalene Drugs Sales by Application (2027-2032) & (K Units) Table 59. Global Adapalene Drugs Sales Market Share in Volume by Application (2027-2032) Table 60. Global Adapalene Drugs Sales by Application (2027-2032) & (US$ Million) Table 61. Global Adapalene Drugs Sales Market Share in Value by Application (2027-2032) Table 62. Global Adapalene Drugs Price by Application (2027-2032) & (US$/Unit) Table 63. North America Adapalene Drugs Sales by Application (2021-2026) & (K Units) Table 64. North America Adapalene Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Adapalene Drugs Sales by Application (2021-2026) & (K Units) Table 66. Europe Adapalene Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Adapalene Drugs Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Adapalene Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Adapalene Drugs Sales by Application (2021-2026) & (K Units) Table 70. Latin America Adapalene Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Adapalene Drugs Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Adapalene Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Wuhan Nuoan Pharmaceutical Company Information Table 74. Wuhan Nuoan Pharmaceutical Business Overview Table 75. Wuhan Nuoan Pharmaceutical Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Wuhan Nuoan Pharmaceutical Adapalene Drugs Product Portfolio Table 77. Wuhan Nuoan Pharmaceutical Recent Development Table 78. Sichuan Med-Shine Pharmaceutical Company Information Table 79. Sichuan Med-Shine Pharmaceutical Business Overview Table 80. Sichuan Med-Shine Pharmaceutical Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Sichuan Med-Shine Pharmaceutical Adapalene Drugs Product Portfolio Table 82. Sichuan Med-Shine Pharmaceutical Recent Development Table 83. Jiangsu Fubang Pharmaceutical Company Information Table 84. Jiangsu Fubang Pharmaceutical Business Overview Table 85. Jiangsu Fubang Pharmaceutical Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Jiangsu Fubang Pharmaceutical Adapalene Drugs Product Portfolio Table 87. Jiangsu Fubang Pharmaceutical Recent Development Table 88. Heilongjiang Fuhe Pharmaceutical Company Information Table 89. Heilongjiang Fuhe Pharmaceutical Business Overview Table 90. Heilongjiang Fuhe Pharmaceutical Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Heilongjiang Fuhe Pharmaceutical Adapalene Drugs Product Portfolio Table 92. Heilongjiang Fuhe Pharmaceutical Recent Development Table 93. HEC Pharm Company Information Table 94. HEC Pharm Business Overview Table 95. HEC Pharm Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. HEC Pharm Adapalene Drugs Product Portfolio Table 97. HEC Pharm Recent Development Table 98. Beijing Foyou Pharmaceutical Company Information Table 99. Beijing Foyou Pharmaceutical Business Overview Table 100. Beijing Foyou Pharmaceutical Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Beijing Foyou Pharmaceutical Adapalene Drugs Product Portfolio Table 102. Beijing Foyou Pharmaceutical Recent Development Table 103. Taro Pharmaceutical Company Information Table 104. Taro Pharmaceutical Business Overview Table 105. Taro Pharmaceutical Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Taro Pharmaceutical Adapalene Drugs Product Portfolio Table 107. Taro Pharmaceutical Recent Development Table 108. Sandoz Company Information Table 109. Sandoz Business Overview Table 110. Sandoz Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Sandoz Adapalene Drugs Product Portfolio Table 112. Sandoz Recent Development Table 113. Glenmark Company Information Table 114. Glenmark Business Overview Table 115. Glenmark Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Glenmark Adapalene Drugs Product Portfolio Table 117. Glenmark Recent Development Table 118. Galderma Company Information Table 119. Galderma Business Overview Table 120. Galderma Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Galderma Adapalene Drugs Product Portfolio Table 122. Galderma Recent Development Table 123. Encube Ethicals Company Information Table 124. Encube Ethicals Business Overview Table 125. Encube Ethicals Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Encube Ethicals Adapalene Drugs Product Portfolio Table 127. Encube Ethicals Recent Development Table 128. Bausch Health Company Information Table 129. Bausch Health Business Overview Table 130. Bausch Health Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Bausch Health Adapalene Drugs Product Portfolio Table 132. Bausch Health Recent Development Table 133. Alembic Company Information Table 134. Alembic Business Overview Table 135. Alembic Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Alembic Adapalene Drugs Product Portfolio Table 137. Alembic Recent Development Table 138. Actavis Company Information Table 139. Actavis Business Overview Table 140. Actavis Adapalene Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Actavis Adapalene Drugs Product Portfolio Table 142. Actavis Recent Development Table 143. North America Adapalene Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. North America Adapalene Drugs Sales by Country (2021-2026) & (K Units) Table 145. North America Adapalene Drugs Sales Market Share by Country (2021-2026) Table 146. North America Adapalene Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 147. North America Adapalene Drugs Sales Market Share Forecast by Country (2027-2032) Table 148. North America Adapalene Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America Adapalene Drugs Market Size by Country (2021-2026) & (US$ Million) Table 150. North America Adapalene Drugs Market Share by Country (2021-2026) Table 151. North America Adapalene Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America Adapalene Drugs Market Share Forecast by Country (2027-2032) Table 153. Europe Adapalene Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 154. Europe Adapalene Drugs Sales by Country (2021-2026) & (K Units) Table 155. Europe Adapalene Drugs Sales Market Share by Country (2021-2026) Table 156. Europe Adapalene Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 157. Europe Adapalene Drugs Sales Market Share Forecast by Country (2027-2032) Table 158. Europe Adapalene Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Europe Adapalene Drugs Market Size by Country (2021-2026) & (US$ Million) Table 160. Europe Adapalene Drugs Market Share by Country (2021-2026) Table 161. Europe Adapalene Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Europe Adapalene Drugs Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Adapalene Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Adapalene Drugs Sales by Country (2021-2026) & (K Units) Table 165. Asia-Pacific Adapalene Drugs Sales Market Share by Country (2021-2026) Table 166. Asia-Pacific Adapalene Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 167. Asia-Pacific Adapalene Drugs Sales Market Share Forecast by Country (2027-2032) Table 168. Asia-Pacific Adapalene Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Asia-Pacific Adapalene Drugs Market Size by Country (2021-2026) & (US$ Million) Table 170. Asia-Pacific Adapalene Drugs Market Share by Country (2021-2026) Table 171. Asia-Pacific Adapalene Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Asia-Pacific Adapalene Drugs Market Share Forecast by Country (2027-2032) Table 173. Latin America Adapalene Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 174. Latin America Adapalene Drugs Sales by Country (2021-2026) & (K Units) Table 175. Latin America Adapalene Drugs Sales Market Share by Country (2021-2026) Table 176. Latin America Adapalene Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 177. Latin America Adapalene Drugs Sales Market Share Forecast by Country (2027-2032) Table 178. Latin America Adapalene Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Latin America Adapalene Drugs Market Size by Country (2021-2026) & (US$ Million) Table 180. Latin America Adapalene Drugs Market Share by Country (2021-2026) Table 181. Latin America Adapalene Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Latin America Adapalene Drugs Market Share Forecast by Country (2027-2032) Table 183. Middle East and Africa Adapalene Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 184. Middle East and Africa Adapalene Drugs Sales by Country (2021-2026) & (K Units) Table 185. Middle East and Africa Adapalene Drugs Sales Market Share by Country (2021-2026) Table 186. Middle East and Africa Adapalene Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 187. Middle East and Africa Adapalene Drugs Sales Market Share Forecast by Country (2027-2032) Table 188. Middle East and Africa Adapalene Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Middle East and Africa Adapalene Drugs Market Size by Country (2021-2026) & (US$ Million) Table 190. Middle East and Africa Adapalene Drugs Market Share by Country (2021-2026) Table 191. Middle East and Africa Adapalene Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Middle East and Africa Adapalene Drugs Market Share Forecast by Country (2027-2032) Table 193. Key Raw Materials Table 194. Raw Materials Key Suppliers Table 195. Adapalene Drugs Distributors List Table 196. Adapalene Drugs Customers List Table 197. Research Programs/Design for This Report Table 198. Authors List of This Report Table 199. Secondary Sources Table 200. Primary Sources List of Figures Figure 1. Adapalene Drugs Image Figure 2. Global Adapalene Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Adapalene Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Adapalene Drugs Sales (2021-2032) & (K Units) Figure 5. Gel Image Figure 6. Global Gel Sales YoY Growth (2021-2032) & (K Units) Figure 7. Solution Image Figure 8. Global Solution Sales YoY Growth (2021-2032) & (K Units) Figure 9. Cream Image Figure 10. Global Cream Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Adapalene Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Adapalene Drugs Market Share by Type 2025 VS 2032 Figure 15. North America Adapalene Drugs Sales Market Share in Volume by Type in 2025 Figure 16. North America Adapalene Drugs Sales Market Share in Value by Type in 2025 Figure 17. Europe Adapalene Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Europe Adapalene Drugs Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Adapalene Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Adapalene Drugs Sales Market Share in Value by Type in 2025 Figure 21. Latin America Adapalene Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Adapalene Drugs Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Adapalene Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Adapalene Drugs Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Adapalene Drugs Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Acne Image Figure 28. Global Acne Sales YoY Growth (2021-2032) & (K Units) Figure 29. Keratosis Pilaris Image Figure 30. Global Keratosis Pilaris Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Adapalene Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Adapalene Drugs Market Share by Application 2025 VS 2032 Figure 35. North America Adapalene Drugs Sales Market Share in Volume by Application in 2025 Figure 36. North America Adapalene Drugs Sales Market Share in Value by Application in 2025 Figure 37. Europe Adapalene Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Europe Adapalene Drugs Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Adapalene Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Adapalene Drugs Sales Market Share in Value by Application in 2025 Figure 41. Latin America Adapalene Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Adapalene Drugs Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Adapalene Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Adapalene Drugs Sales Market Share in Value by Application in 2025 Figure 45. North America Adapalene Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Adapalene Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Adapalene Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Adapalene Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Adapalene Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Adapalene Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Adapalene Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Adapalene Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Adapalene Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Adapalene Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Adapalene Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Adapalene Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Adapalene Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Adapalene Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Adapalene Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Adapalene Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Adapalene Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Adapalene Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Adapalene Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Adapalene Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Adapalene Drugs Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Adapalene Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Gel
  • Solution
  • Cream
  • Others
Applications
  • Acne
  • Keratosis Pilaris
  • Others
Companies covered
  • Wuhan Nuoan Pharmaceutical
  • Sichuan Med-Shine Pharmaceutical
  • Jiangsu Fubang Pharmaceutical
  • Heilongjiang Fuhe Pharmaceutical
  • HEC Pharm
  • Beijing Foyou Pharmaceutical
  • Taro Pharmaceutical
  • Sandoz
  • Glenmark
  • Galderma
  • Encube Ethicals
  • Bausch Health
  • Alembic
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Adapalene Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Adapalene Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Adapalene Drugs Market by Type
  6. 1.3.1 Gel
  7. 1.3.2 Solution
  8. 1.3.3 Cream
  9. 1.3.4 Others
  10. 1.4 Global Adapalene Drugs Market Size by Type
  11. 1.4.1 Global Adapalene Drugs Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Adapalene Drugs Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Adapalene Drugs Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Adapalene Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Adapalene Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Adapalene Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Adapalene Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Adapalene Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Adapalene Drugs Industry Trends
  2. 2.2 Adapalene Drugs Industry Drivers
  3. 2.3 Adapalene Drugs Industry Opportunities and Challenges
  4. 2.4 Adapalene Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Adapalene Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Adapalene Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Adapalene Drugs Price (2021-2026)
  4. 3.4 Global Adapalene Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Adapalene Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Adapalene Drugs Company, Product Type & Application
  7. 3.7 Global Adapalene Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Adapalene Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Adapalene Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Adapalene Drugs Tier 1, Tier 2, and Tier 3
4 Adapalene Drugs Regional Status and Outlook
  1. 4.1 Global Adapalene Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Adapalene Drugs Historic Market Size by Region
  3. 4.2.1 Global Adapalene Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Adapalene Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Adapalene Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Adapalene Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Adapalene Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Adapalene Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Adapalene Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Adapalene Drugs by Application
  1. 5.1 Adapalene Drugs Market by Application
  2. 5.1.1 Acne
  3. 5.1.2 Keratosis Pilaris
  4. 5.1.3 Others
  5. 5.2 Global Adapalene Drugs Market Size by Application
  6. 5.2.1 Global Adapalene Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Adapalene Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Adapalene Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Adapalene Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Adapalene Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Adapalene Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Adapalene Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Adapalene Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Wuhan Nuoan Pharmaceutical
  2. 6.1.1 Wuhan Nuoan Pharmaceutical Company Information
  3. 6.1.2 Wuhan Nuoan Pharmaceutical Business Overview
  4. 6.1.3 Wuhan Nuoan Pharmaceutical Adapalene Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Wuhan Nuoan Pharmaceutical Adapalene Drugs Product Portfolio
  6. 6.1.5 Wuhan Nuoan Pharmaceutical Recent Developments
  7. 6.2 Sichuan Med-Shine Pharmaceutical
  8. 6.2.1 Sichuan Med-Shine Pharmaceutical Company Information
  9. 6.2.2 Sichuan Med-Shine Pharmaceutical Business Overview
  10. 6.2.3 Sichuan Med-Shine Pharmaceutical Adapalene Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sichuan Med-Shine Pharmaceutical Adapalene Drugs Product Portfolio
  12. 6.2.5 Sichuan Med-Shine Pharmaceutical Recent Developments
  13. 6.3 Jiangsu Fubang Pharmaceutical
  14. 6.3.1 Jiangsu Fubang Pharmaceutical Company Information
  15. 6.3.2 Jiangsu Fubang Pharmaceutical Business Overview
  16. 6.3.3 Jiangsu Fubang Pharmaceutical Adapalene Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Jiangsu Fubang Pharmaceutical Adapalene Drugs Product Portfolio
  18. 6.3.5 Jiangsu Fubang Pharmaceutical Recent Developments
  19. 6.4 Heilongjiang Fuhe Pharmaceutical
  20. 6.4.1 Heilongjiang Fuhe Pharmaceutical Company Information
  21. 6.4.2 Heilongjiang Fuhe Pharmaceutical Business Overview
  22. 6.4.3 Heilongjiang Fuhe Pharmaceutical Adapalene Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Heilongjiang Fuhe Pharmaceutical Adapalene Drugs Product Portfolio
  24. 6.4.5 Heilongjiang Fuhe Pharmaceutical Recent Developments
  25. 6.5 HEC Pharm
  26. 6.5.1 HEC Pharm Company Information
  27. 6.5.2 HEC Pharm Business Overview
  28. 6.5.3 HEC Pharm Adapalene Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 HEC Pharm Adapalene Drugs Product Portfolio
  30. 6.5.5 HEC Pharm Recent Developments
  31. 6.6 Beijing Foyou Pharmaceutical
  32. 6.6.1 Beijing Foyou Pharmaceutical Company Information
  33. 6.6.2 Beijing Foyou Pharmaceutical Business Overview
  34. 6.6.3 Beijing Foyou Pharmaceutical Adapalene Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Beijing Foyou Pharmaceutical Adapalene Drugs Product Portfolio
  36. 6.6.5 Beijing Foyou Pharmaceutical Recent Developments
  37. 6.7 Taro Pharmaceutical
  38. 6.7.1 Taro Pharmaceutical Company Information
  39. 6.7.2 Taro Pharmaceutical Business Overview
  40. 6.7.3 Taro Pharmaceutical Adapalene Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Taro Pharmaceutical Adapalene Drugs Product Portfolio
  42. 6.7.5 Taro Pharmaceutical Recent Developments
  43. 6.8 Sandoz
  44. 6.8.1 Sandoz Company Information
  45. 6.8.2 Sandoz Business Overview
  46. 6.8.3 Sandoz Adapalene Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sandoz Adapalene Drugs Product Portfolio
  48. 6.8.5 Sandoz Recent Developments
  49. 6.9 Glenmark
  50. 6.9.1 Glenmark Company Information
  51. 6.9.2 Glenmark Business Overview
  52. 6.9.3 Glenmark Adapalene Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Glenmark Adapalene Drugs Product Portfolio
  54. 6.9.5 Glenmark Recent Developments
  55. 6.10 Galderma
  56. 6.10.1 Galderma Company Information
  57. 6.10.2 Galderma Business Overview
  58. 6.10.3 Galderma Adapalene Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Galderma Adapalene Drugs Product Portfolio
  60. 6.10.5 Galderma Recent Developments
  61. 6.11 Encube Ethicals
  62. 6.11.1 Encube Ethicals Company Information
  63. 6.11.2 Encube Ethicals Business Overview
  64. 6.11.3 Encube Ethicals Adapalene Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Encube Ethicals Adapalene Drugs Product Portfolio
  66. 6.11.5 Encube Ethicals Recent Developments
  67. 6.12 Bausch Health
  68. 6.12.1 Bausch Health Company Information
  69. 6.12.2 Bausch Health Business Overview
  70. 6.12.3 Bausch Health Adapalene Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Bausch Health Adapalene Drugs Product Portfolio
  72. 6.12.5 Bausch Health Recent Developments
  73. 6.13 Alembic
  74. 6.13.1 Alembic Company Information
  75. 6.13.2 Alembic Business Overview
  76. 6.13.3 Alembic Adapalene Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Alembic Adapalene Drugs Product Portfolio
  78. 6.13.5 Alembic Recent Developments
  79. 6.14 Actavis
  80. 6.14.1 Actavis Company Information
  81. 6.14.2 Actavis Business Overview
  82. 6.14.3 Actavis Adapalene Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Actavis Adapalene Drugs Product Portfolio
  84. 6.14.5 Actavis Recent Developments
7 North America by Country
  1. 7.1 North America Adapalene Drugs Sales by Country
  2. 7.1.1 North America Adapalene Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Adapalene Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Adapalene Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Adapalene Drugs Market Size by Country
  6. 7.2.1 North America Adapalene Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Adapalene Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Adapalene Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Adapalene Drugs Sales by Country
  2. 8.1.1 Europe Adapalene Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Adapalene Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Adapalene Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Adapalene Drugs Market Size by Country
  6. 8.2.1 Europe Adapalene Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Adapalene Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Adapalene Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Adapalene Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Adapalene Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Adapalene Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Adapalene Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Adapalene Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Adapalene Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Adapalene Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Adapalene Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Adapalene Drugs Sales by Country
  2. 10.1.1 South America Adapalene Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Adapalene Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Adapalene Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Adapalene Drugs Market Size by Country
  6. 10.2.1 South America Adapalene Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Adapalene Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Adapalene Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Adapalene Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Adapalene Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Adapalene Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Adapalene Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Adapalene Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Adapalene Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Adapalene Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Adapalene Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Adapalene Drugs Value Chain Analysis
  2. 12.1.1 Adapalene Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Adapalene Drugs Production Mode & Process
  7. 12.2 Adapalene Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Adapalene Drugs Distributors
  10. 12.2.3 Adapalene Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst